The Return Of Second Medical Use Patents: Encouraging R&D Or Stifling Innovation?
Industry is eagerly awaiting this month’s judgement of the UK Supreme Court on whether a rule that constitutes a serious obstacle to enforcing patents for important medicines will be removed or modified, say legal experts Charlotte Tillett and Camille Arnold.
